The high incidence of bone metastasis in PCC, particularly SRCC, is likely driven by its distinct clinicopathological features, including low E‐cadherin expression, which may partly explain the increased metastatic potential. The gene discussed is CDH1; the disease is adrenal gland pheochromocytoma.